Heart News and Research

RSS

Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery

Endotis Pharma, a world leader in the development of neutralizable anticoagulants, today announced enrolment of the first patients into a Phase IIa study using EP217609 and its specific antidote avidin to manage coagulation during open-heart surgery.

22 Jun 2011

Strathclyde scientists receive British Heart Foundation grant to study hypertension

Scientists at the University of Strathclyde's Institute of Pharmacy and Biomedical Sciences, have recently been awarded almost -155,000 by the British Heart Foundation to conduct a two year investigation aimed at improving the treatment of hypertension.

22 Jun 2011

Pycnogenol, CoQ10 combination boost heart function

A recent study published in Panminerva Medica reveals that a Pycnogenol and Coenzyme Q10 combination taken by stable heart failure patients as an adjunct to medical treatment naturally strengthens the heart, increasing the blood volume ejected with each beat.

22 Jun 2011

Gastric bypass surgery reduces inflammation linked with cancer and diabetes

New research shows that gastric bypass significantly reduces the inflammation associated with diseases including cancer and diabetes - more proof of the overall health benefits of such surgery beyond weight loss.

22 Jun 2011

NCDs responsible for majority of deaths worldwide and cost trillions, report says

Nearly two-thirds of deaths worldwide are caused by non-communicable diseases such as heart and lung disease, cancer, and diabetes, which are increasingly prevalent and cost the global economy trillions of dollars, according to a U.N. report and preliminary results from a new study announced Monday at a press conference to preview the September U.N. High Level Meeting on NCDs, the Associated Press/MSNBC.com reports.

22 Jun 2011

Genetic mutation linked to peripartum cardiomyopathy during pregnancy

Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified the first genetic mutation ever associated with a mysterious and potentially devastating form of heart disease that affects women in the final weeks of pregnancy or the first few months after delivery.

22 Jun 2011

Exercise helps overcome side effects of cancer, improves survival

Brain cancer patients who are able to exercise live significantly longer than sedentary patients, scientists at the Duke Cancer Institute report.

22 Jun 2011

Maternal smoking 'imprints' unhealthy set of characteristics on unborn babies

Researchers in Australia have discovered that mothers who smoke during pregnancy are causing developmental changes to their unborn babies that lead to them having lower levels of the type of cholesterol that is known to protect against heart disease in later life - high-density lipoprotein (HDL) cholesterol.

22 Jun 2011

Smoking during pregnancy lowers offspring's HDL cholesterol, greater risk of heart disease later

Scientists said on Tuesday that mothers who smoke while pregnant are causing changes to their unborn babies that can lead them to have less of a type of cholesterol known to protect against heart disease.

22 Jun 2011

Palatin receives U.S. patent titled ‘Amino Acid Surrogates for Peptidic Constructs'

Palatin Technologies, Inc. announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 7,964,181, titled "Amino Acid Surrogates for Peptidic Constructs."

22 Jun 2011

Every second counts when performing cardiac arrest resuscitation

A new study has found the number of people who survive after suffering a cardiac arrest outside a hospital drops significantly if the pause between stopping CPR and using a defibrillator to administer an electric shock is longer than 20 seconds.

21 Jun 2011

Black patients with heart attack wait longer at hospitals to get life-saving procedures

Black patients having a heart attack wait longer at hospitals than white patients to get advanced procedures that will restore blood flow to their hearts, according to a University of Michigan Health System study.

21 Jun 2011

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.

21 Jun 2011

Adequate midwifery could save 3.6 million lives, new report shows

Up to 3.6 million deaths could be avoided each year in 58 developing countries if midwifery services are upgraded by 2015, according to a major new report released here today by UNFPA, the United Nations Population Fund, and partners.

20 Jun 2011

Genetic biomarker may help identify patients at increased risk of bypass surgery

Outcomes of bypass surgery to repair blocked arteries in the legs tend to be better in the roughly one-in-five people who have inherited a specific genetic variation from both parents, according to a study presented at the late-breaking clinical trials session of the Vascular Annual Meeting in Chicago on June 18, 2011.

20 Jun 2011

Hardin Memorial Hospital selects ProVation Order Sets

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Hardin Memorial Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the organization's electronic order set solution.

20 Jun 2011

Valencell receives $5.5M in Series B venture investment

Valencell, an innovator in mobile health and fitness technology, announced today that it has received $5.5 million in Series B venture investment. The round was led by Best Buy Capital, the investment group of Best Buy Co., Inc., with participation from Series A investors TDF and True Ventures.

20 Jun 2011

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Randox Laboratories, the international clinical diagnostics company, has today launched an automated laboratory assay for Heart-type Fatty Acid Binding Protein (H-FABP), to improve the diagnosis and management of patients with suspected acute coronary syndrome (ACS).

From Randox Laboratories Ltd. 20 Jun 2011

Neovasc first quarter revenues increase 10% to $1,169,920

Neovasc Inc., today announced financial results for the three months ended March 31, 2011 and advances in its product development programs.

20 Jun 2011

Medtronic Valiant stent graft safe and effective for patients with thoracic aortic aneurysm

An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant Thoracic Stent Graft System from Medtronic, Inc., delivered excellent clinical results through one year of patient follow-up in the company's U.S. pivotal study, VALOR II, according to data presented today at a meeting for vascular surgeons.

From Medtronic 20 Jun 2011

Heart News and Research

Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery

Strathclyde scientists receive British Heart Foundation grant to study hypertension

Pycnogenol, CoQ10 combination boost heart function

Gastric bypass surgery reduces inflammation linked with cancer and diabetes

NCDs responsible for majority of deaths worldwide and cost trillions, report says

Genetic mutation linked to peripartum cardiomyopathy during pregnancy

Exercise helps overcome side effects of cancer, improves survival

Maternal smoking 'imprints' unhealthy set of characteristics on unborn babies

Smoking during pregnancy lowers offspring's HDL cholesterol, greater risk of heart disease later

Palatin receives U.S. patent titled ‘Amino Acid Surrogates for Peptidic Constructs'

Every second counts when performing cardiac arrest resuscitation

Black patients with heart attack wait longer at hospitals to get life-saving procedures

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Adequate midwifery could save 3.6 million lives, new report shows

Genetic biomarker may help identify patients at increased risk of bypass surgery

Hardin Memorial Hospital selects ProVation Order Sets

Valencell receives $5.5M in Series B venture investment

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Neovasc first quarter revenues increase 10% to $1,169,920

Medtronic Valiant stent graft safe and effective for patients with thoracic aortic aneurysm

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News